Zscaler, Inc. (NASDAQ:ZS – Get Free Report) insider Adam Geller sold 2,817 shares of Zscaler stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $122.60, for a total value of $345,364.20. Following the sale, the insider directly owned 42,314 shares in the company, valued at $5,187,696.40. The trade was a 6.24% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Adam Geller also recently made the following trade(s):
- On Tuesday, June 16th, Adam Geller sold 1,940 shares of Zscaler stock. The stock was sold at an average price of $126.43, for a total value of $245,274.20.
Zscaler Trading Up 0.9%
NASDAQ:ZS opened at $127.27 on Thursday. Zscaler, Inc. has a 1 year low of $114.63 and a 1 year high of $336.99. The stock has a market cap of $20.58 billion, a price-to-earnings ratio of -265.14, a PEG ratio of 78.89 and a beta of 0.97. The business has a fifty day moving average of $141.54 and a 200-day moving average of $170.03. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.86 and a current ratio of 1.86.
Key Zscaler News
Here are the key news stories impacting Zscaler this week:
- Positive Sentiment: Zscaler’s Project AI-Guardian expansion is being framed as a strategic win, as it broadens the company’s zero-trust security offering for enterprise AI environments and could strengthen long-term demand. Zscaler (ZS) Expands Project AI-Guardian to Provide Unified Security for Enterprise AI Ecosystems
- Positive Sentiment: Analysts and market commentary highlighted momentum in Z-Flex bookings, pointing to stronger customer spending, wider platform adoption, and improving revenue visibility through rising TCV, ARR, and RPO. Will the Momentum in Z-Flex Booking Fuel More Growth for Zscaler?
- Positive Sentiment: Coverage also said Zscaler landed a major healthcare win and noted rising profile from index additions, which may support sales momentum and investor interest. Zscaler (ZS) Lands A Major Healthcare Win As Index Additions Raise Its Profile
- Neutral Sentiment: One insider, Adam Geller, sold 2,817 shares in a pre-arranged 10b5-1 transaction; the sale is routine, but insider selling can still slightly pressure sentiment. SEC Form 4 Filing
- Negative Sentiment: Pomerantz LLP said it is investigating claims on behalf of Zscaler investors, creating a legal overhang that could weigh on the stock. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zscaler, Inc. – ZS
Institutional Trading of Zscaler
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Goldstream Capital Management Ltd grew its position in Zscaler by 0.3% in the third quarter. Goldstream Capital Management Ltd now owns 12,450 shares of the company’s stock worth $3,731,000 after buying an additional 34 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund boosted its stake in shares of Zscaler by 1.4% during the 3rd quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 2,569 shares of the company’s stock worth $770,000 after acquiring an additional 36 shares in the last quarter. Advisor OS LLC grew its holdings in shares of Zscaler by 4.6% in the 3rd quarter. Advisor OS LLC now owns 879 shares of the company’s stock worth $263,000 after acquiring an additional 39 shares during the last quarter. Parallel Advisors LLC raised its position in shares of Zscaler by 10.9% during the third quarter. Parallel Advisors LLC now owns 397 shares of the company’s stock worth $119,000 after purchasing an additional 39 shares during the period. Finally, Smartleaf Asset Management LLC lifted its holdings in shares of Zscaler by 7.5% during the second quarter. Smartleaf Asset Management LLC now owns 648 shares of the company’s stock valued at $204,000 after purchasing an additional 45 shares during the last quarter. 46.45% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
ZS has been the subject of a number of research analyst reports. Scotiabank reduced their price target on shares of Zscaler from $190.00 to $175.00 and set a “sector outperform” rating for the company in a research note on Wednesday, May 27th. Robert W. Baird lowered their price objective on shares of Zscaler from $265.00 to $230.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 27th. Stephens reissued an “overweight” rating and set a $200.00 target price on shares of Zscaler in a report on Friday, June 12th. Morgan Stanley cut their target price on Zscaler from $155.00 to $145.00 and set an “equal weight” rating for the company in a research report on Wednesday, May 27th. Finally, The Goldman Sachs Group reaffirmed a “neutral” rating and set a $179.00 price target on shares of Zscaler in a research note on Wednesday, May 27th. Thirty-four investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $214.33.
Read Our Latest Research Report on ZS
About Zscaler
Zscaler is a cloud security company that delivers a cloud-native platform to protect users, applications and data as organizations move away from traditional, network-centric security architectures. The company focuses on a zero trust approach that assumes no implicit trust for users or devices, providing secure access to the internet, SaaS applications and private applications regardless of where users are located. Zscaler positions its services as an alternative to legacy appliances and site-centric VPNs, aiming to simplify security while enabling modern, distributed workforces.
Key offerings are built around the Zscaler Zero Trust Exchange, a multi-tenant cloud platform that enforces security and access policies in-line.
See Also
- Five stocks we like better than Zscaler
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Zscaler Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zscaler and related companies with MarketBeat.com's FREE daily email newsletter.
